Cross-reactive T cell immunity against novel coronaviruses with pandemic potential, predictable from spike sequence conservation
Clinical and Experimental Immunology · 30.10.2026
DOI: 10.1093/cei/uxag068 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Immunology, online erschienen am 30.10.2026. Verfasst von Nguyen Thi Thu Hong und 20 weiteren Autor:innen. Beteiligte Einrichtung: Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, Coronavirus Infections, T-Lymphocytes, Betacoronavirus. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, NIHR, NIHR Global Research Professorship.
Abstract (Originalsprache)
Widespread SARS-CoV-2 infection and vaccination have reshaped global immunity to coronaviruses. Whether this immunity extends to animal sarbecoviruses with spillover potential remains unknown. We assessed cross-reactive memory T-cell responses to spike proteins from five relevant human angiotensin-converting enzyme 2 (hACE2)-dependent sarbecoviruses and MERS-CoV in healthcare workers in the UK and Vietnam. Limited SARS-CoV-2 specific or cross-reactive responses were seen in pre-pandemic samples. However, in samples collected from vaccinated donors at 3-24 months after booster vaccination, cross-reactive T-cell responses across the hACE2-dependent sarbecoviruses were detected. There was a strong correlation between the magnitude of responses and the level of viral sequence identity. This relationship was reproduced across cohorts in the UK and Vietnam. These findings indicate that post-pandemic populations possess measurable cellular immunity to genetically related sarbecoviruses and suggest that the degree of T-cell cross-recognition can be predicted from the spike protein sequence conservation. Such data provide an immunological framework for assessing vulnerability to future sarbecovirus spillover.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
- Centre for Global Health Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
- Department of Experimental Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
- Department of Biochemistry and Molecular Biology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
- Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam.
- Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK.
ORCID-Profile: Nguyen Thi Thu Hong, Mohammad Ali, Paul Klenerman, Le Van Tan
Förderung
- Wellcome Trust
- NIHR
- NIHR Global Research Professorship
Zitieren
APA
Hong, N. T. T., Kronsteiner, B., Thanh, T. T., Zewdie, M., Ali, M., Anh, N. T., Nguyet, L. A., Dung, N. T., Toan, L. M., Mongkolsapaya, J., Tan, C. W., Truong, N. T., Thanh, L. K., Nhu, L. N. T., Thuy, C. T., Chau, N. V. V., Thwaites, G., Klenerman, P., Dunachie, S. J., …, & for SEACOVARIANTS Consortium (2026). Cross-reactive T cell immunity against novel coronaviruses with pandemic potential, predictable from spike sequence conservation. Clinical and Experimental Immunology. https://doi.org/10.1093/cei/uxag068
Vancouver
Hong NTT, Kronsteiner B, Thanh TT, Zewdie M, Ali M, Anh NT, et al. Cross-reactive T cell immunity against novel coronaviruses with pandemic potential, predictable from spike sequence conservation. Clinical and Experimental Immunology. 2026. doi:10.1093/cei/uxag068
BibTeX
@article{Hong2026,
author = {Hong, Nguyen Thi Thu and Kronsteiner, Barbara and Thanh, Tran Tan and Zewdie, Martha and Ali, Mohammad and Anh, Nguyen To and Nguyet, Lam Anh and Dung, Nguyen Thanh and Toan, Le Mau and Mongkolsapaya, Juthathip and Tan, Chee Wah and Truong, Nguyen Thanh and Thanh, Le Kim and Nhu, Le Nguyen Truc and Thuy, Cao Thu and Chau, Nguyen Van Vinh and Thwaites, Guy and Klenerman, Paul and Dunachie, Susanna J and Tan, Le Van and for SEACOVARIANTS Consortium, for SEACOVARIANTS Consortium},
title = {Cross-reactive T cell immunity against novel coronaviruses with pandemic potential, predictable from spike sequence conservation},
journal = {Clinical and Experimental Immunology},
year = {2026},
doi = {10.1093/cei/uxag068}
}
EUVIMED